Arteris (AIP) CEO-linked Bayview Legacy LLC sells 70,000 shares under 10b5-1 plan

Filing Impact

(Very High)

Filing Sentiment

(Negative)

Form Type

Rhea-AI Filing Summary

Arteris, Inc. director, President and CEO K. Charles Janac reported an indirect open-market sale of 70,000 shares of common stock at a weighted average price of $31.1998 per share through Bayview Legacy, LLC. The sale was executed under a pre-arranged Rule 10b5-1 trading plan adopted on March 5, 2025.

Following the sale, Bayview Legacy, LLC held 9,049,071 shares of Arteris common stock. Janac also reported ownership of 196,729 shares held directly and 56,252 shares held indirectly through the Charles and Lydia Janac Trust, for which he serves as trustee.

Insider Trade Summary 10b5-1

Net Seller: 70,000 shares ($2,183,986)

Net Sell 3 txns

Insider JANAC K CHARLES

Role President and CEO

Sold 70,000 shs ($2.18M)

Type	Security	Shares	Price	Value
Sale	Common Stock	70,000	$31.1998	$2.18M
holding	Common Stock	--	--	--
holding	Common Stock	--	--	--

Holdings After Transaction: Common Stock — 9,049,071 shares (Indirect, Bayview Legacy, LLC); Common Stock — 196,729 shares (Direct, null)

Footnotes (1)

Transaction made pursuant to a 10b5-1 trading plan that was adopted by the Reporting Person on March 5, 2025. The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $29.19 to $32.07 inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The Reporting Person is the manager of Bayview Legacy, LLC and as such is deemed to have voting and dispositive power of the shares beneficially owned by Bayview Legacy, LLC. The shares are held by Charles and Lydia Janac Trust, for which the Reporting Person serves as trustee.

Key Figures

Shares sold: 70,000 shares Weighted average sale price: $31.1998 per share Sale price range: $29.19–$32.07 per share +3 more

6 metrics

Shares sold 70,000 shares Indirect open-market sale by Bayview Legacy, LLC on 2026-05-08

Weighted average sale price $31.1998 per share Price reported for the 70,000-share sale

Sale price range $29.19–$32.07 per share Range of individual trade prices for the sold shares

Bayview Legacy holdings after sale 9,049,071 shares Indirectly beneficially owned via Bayview Legacy, LLC after transaction

Direct holdings after transaction 196,729 shares Shares held directly by K. Charles Janac after reported transactions

Trust holdings after transaction 56,252 shares Shares held by Charles and Lydia Janac Trust after reported transactions

Key Terms

Rule 10b5-1 trading plan, weighted average sale price, voting and dispositive power, beneficially owned

4 terms

Rule 10b5-1 trading plan regulatory

"Transaction made pursuant to a 10b5-1 trading plan that was adopted by the Reporting Person on March 5, 2025."

A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.

weighted average sale price financial

"The price reported in Column 4 is a weighted average sale price."

voting and dispositive power financial

"The Reporting Person is the manager of Bayview Legacy, LLC and as such is deemed to have voting and dispositive power of the shares beneficially owned by Bayview Legacy, LLC."

beneficially owned financial

"The Reporting Person is the manager of Bayview Legacy, LLC and as such is deemed to have voting and dispositive power of the shares beneficially owned by Bayview Legacy, LLC."

Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.

Form 4 Insider Transactions: What Each Field Means →

05/12/2026 - 05:13 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

JANAC K CHARLES

(Last)

(First)

(Middle)

C/O ARTERIS, INC.

900 E. HAMILTON AVE., SUITE 300

(Street)

CAMPBELL

CALIFORNIA

95008

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Arteris, Inc. [ AIP ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	X	10% Owner
X	Officer (give title below)		Other (specify below)
	President and CEO

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/08/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	05/08/2026		S⁽¹⁾		70,000	D	$31.1998⁽²⁾	9,049,071	I	Bayview Legacy, LLC⁽³⁾
Common Stock								196,729	D
Common Stock								56,252	I	Charles and Lydia Janac Trust⁽⁴⁾

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. Transaction made pursuant to a 10b5-1 trading plan that was adopted by the Reporting Person on March 5, 2025.

2. The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $29.19 to $32.07 inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

3. The Reporting Person is the manager of Bayview Legacy, LLC and as such is deemed to have voting and dispositive power of the shares beneficially owned by Bayview Legacy, LLC.

4. The shares are held by Charles and Lydia Janac Trust, for which the Reporting Person serves as trustee.

Remarks:

	/s/ Paul Alpern, as Attorney-in-Fact for JANAC K CHARLES	05/12/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What insider transaction did Arteris (AIP) report for K. Charles Janac?

Arteris reported that K. Charles Janac indirectly sold 70,000 shares. The shares of common stock were sold by Bayview Legacy, LLC in an open-market transaction at a weighted average price of $31.1998 per share, as disclosed in the Form 4 filing.

Was the Arteris (AIP) insider sale by K. Charles Janac pre-planned?

Yes, the disclosed sale was made under a Rule 10b5-1 trading plan. The filing states the transaction occurred pursuant to a 10b5-1 plan adopted by the reporting person on March 5, 2025, indicating it was pre-arranged rather than timed discretionarily.

How many Arteris (AIP) shares were sold in the reported insider transaction?

A total of 70,000 Arteris common shares were sold indirectly. These shares were sold by Bayview Legacy, LLC, an entity managed by K. Charles Janac, in open-market trades at a weighted average price of $31.1998 per share, within a specified intraday price range.

What price range did Arteris (AIP) shares trade at in the insider sale?

The reported insider sales occurred between $29.19 and $32.07 per share. The Form 4 notes that the $31.1998 figure is a weighted average, and that multiple trades took place within this price range on the transaction date.

How many Arteris (AIP) shares does Bayview Legacy, LLC hold after the sale?

After the transaction, Bayview Legacy, LLC held 9,049,071 Arteris shares. The filing explains that K. Charles Janac, as manager of Bayview Legacy, LLC, is deemed to have voting and dispositive power over these beneficially owned shares.

What other Arteris (AIP) holdings does K. Charles Janac report besides Bayview Legacy, LLC?

Janac reports additional direct and trust holdings of Arteris shares. Following the reported transactions, he directly held 196,729 common shares and indirectly held 56,252 shares through the Charles and Lydia Janac Trust, where he serves as trustee.